Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS Evaluation of Brain Perfusion in Neonatal PHH
NCT03061045Phase 4Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Apr 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of sulfur hexafluoride in hydrocephalus, sponsored by Johns Hopkins University. Planned start Apr 2017; status: withdrawn.
02
Drugs
sulfur hexafluoride
03
Conditions
hydrocephalus
Beyond the preview
Go deeper on NCT03061045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03061045.